Fraunhofer Institute for Interfacial Engineering and Biotechnology IGBEstablishing cutting-edge solutions for drug discovery and delivery
The Fraunhofer Innovation Platform for Drug Discovery and Delivery at the Hebrew University in Jerusalem, Israel, (FIP_DD@HUJI) is a joint research institution of Fraunhofer IGB and the Institute for Drug Research of the Hebrew University. The focus of the Innovation Platform is on discovery and validation of new drug candidates compounds for infectious and inflammatory diseases as well as on development of targeted nanoparticle delivery systems. To contribute to solving these challenges, the Fraunhofer-Gesellschaft has continuously strengthened its collaboration with the Hebrew University of Jerusalem in Israel. The current FIP_DD@HUJI is the continuation of the Fraunhofer Project Center for Drug Discovery and Delivery, which started in October 2018. Initial first bilateral projects were started in 2012, showing the long history of our collaboration.
Our collaboration resulted in several joint publications, patents and industry cooperations, enabling significant progress in the basic understanding of mechanisms in infectious disease and immunity as well as its application with several companies, from the pharmaceutical sector to cosmetics. Our ongoing projects involve the development of cutting-edge ex-vivo skin models and novel drug delivery systems.
This would not have been possible without the enthusiasm of our IGB colleagues. Warm greetings on the occasion of the IGB’s 70th anniversary; we are very much looking forward to another many years of successful collaboration.
Ofra Benny